Literature DB >> 1601197

Frequency specificity of the auditory brain stem response to bone-conducted tones in infants and adults.

J M Nousak1, D R Stapells.   

Abstract

Auditory brain stem responses were obtained from normal-hearing infants and adults in response to bone-conducted 500 and 2000 Hz tones presented in quiet and high-pass noise masking. The tones were presented at 70 (500 and 2000 Hz) and 46 (2000 Hz) dB peak to peak equivalent (re: 1 dyne RMS). The high-pass noise-masked waveforms were subtracted in succession to obtain derived responses, providing estimates of the cochlear regions contributing to the nonmasked responses. Findings indicate that the auditory brain stem response to bone-conducted 500 Hz tones is frequency specific for both infants and adults. For 2000 Hz tones, the results show maximum amplitudes for cochlear regions representing the nominal frequency of the tone for adults. For infants, maximum response amplitudes for the derived responses to 2000 Hz, 70 dB tones were obtained within 1/2 octave of the nominal frequency (1410-2000 Hz). Wave V latencies of the derived responses are similar for both groups for 2000 Hz tones, but shorter for infants to 500 Hz tones, supporting the hypothesis that low-frequency bone-conducted stimuli are effectively more intense in infants than adults.

Entities:  

Mesh:

Year:  1992        PMID: 1601197     DOI: 10.1097/00003446-199204000-00004

Source DB:  PubMed          Journal:  Ear Hear        ISSN: 0196-0202            Impact factor:   3.570


  2 in total

Review 1.  Relations among Auditory Brainstem and Middle Latency Response Measures, Categorical Loudness Judgments, and Their Associated Physical Intensities.

Authors:  Peggy A Korczak; LaGuinn P Sherlock; Monica L Hawley; Craig Formby
Journal:  Semin Hear       Date:  2017-02

2.  Auditory brainstem responses to bone-conducted brief tones in young children with conductive or sensorineural hearing loss.

Authors:  Jennifer L Hatton; Renée M Janssen; David R Stapells
Journal:  Int J Otolaryngol       Date:  2012-09-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.